We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+4.75%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$196M
AUM Growth
+$10.8M
Cap. Flow
+$2.81M
Cap. Flow %
1.44%
Top 10 Hldgs %
23.43%
Holding
98
New
3
Increased
44
Reduced
17
Closed
2

Top Buys

Rank Stock Value
1
TSCO icon
Tractor Supply
TSCO
+$2.51M
2
CVS icon
CVS Health
CVS
+$507K
3
GE icon
GE Aerospace
GE
+$495K
4
OMC icon
Omnicom Group
OMC
+$344K
5
DD icon
DuPont de Nemours
DD
+$336K

Top Sells

Rank Stock Value
1
DE icon
Deere & Co
DE
+$3.43M
2
DD
Du Pont De Nemours E I
DD
+$284K
3
MA icon
Mastercard
MA
+$172K
4
MSFT icon
Microsoft
MSFT
+$104K
5
AMLP icon
Alerian MLP ETF
AMLP
+$59.9K

Sector Composition

Rank Sector Weight
1 Industrials 14.66%
2 Technology 12.95%
3 Financials 12.55%
4 Healthcare 11.49%
5 Consumer Staples 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$5.8M 2.97%
77,913
-1,429
-2% -$104K
CSCO icon
2
Cisco
CSCO
$442B
$4.81M 2.46%
143,097
+2,581
+2% +$82.2K
ABBV icon
3
AbbVie
ABBV
$448B
$4.7M 2.4%
52,869
-10
-0% -$761
MA icon
4
Mastercard
MA
$470B
$4.57M 2.33%
32,362
-1,300
-4% -$172K
INTC icon
5
Intel
INTC
$516B
$4.52M 2.31%
118,744
+2,751
+2% +$97.8K
AAPL icon
6
Apple
AAPL
$4.79T
$4.52M 2.31%
117,260
-868
-0.7% -$33.7K
MMM icon
7
3M
MMM
$89.1B
$4.51M 2.31%
25,720
+59
+0.2% +$10.2K
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.06T
$4.16M 2.13%
22,704
+17
+0.1% +$3K
IWM icon
9
iShares Russell 2000 ETF
IWM
$81.6B
$4.12M 2.11%
27,828
-100
-0.4% -$14.1K
IJR icon
10
iShares Core S&P Small-Cap ETF
IJR
$110B
$4.12M 2.11%
55,528
+3,133
+6% +$220K
MCD icon
11
McDonald's
MCD
$187B
$4.11M 2.1%
26,252
-365
-1% -$57.2K
XOM icon
12
ExxonMobil
XOM
$640B
$4.07M 2.08%
49,689
+4,002
+9% +$318K
IEMG icon
13
iShares Core MSCI Emerging Markets ETF
IEMG
$153B
$4.04M 2.07%
74,875
+497
+0.7% +$26.4K
PEP icon
14
PepsiCo
PEP
$185B
$3.9M 1.99%
35,008
+327
+0.9% +$37.8K
XYL icon
15
Xylem
XYL
$27.6B
$3.88M 1.98%
61,942
-860
-1% -$51.4K
ACN icon
16
Accenture
ACN
$85.7B
$3.79M 1.94%
28,091
-90
-0.3% -$11.7K
KO icon
17
Coca-Cola
KO
$354B
$3.76M 1.92%
83,574
+147
+0.2% +$6.69K
WMT icon
18
Walmart Inc
WMT
$870B
$3.75M 1.92%
144,111
+315
+0.2% +$8.26K
GE icon
19
GE Aerospace
GE
$354B
$3.59M 1.84%
30,994
+4,091
+15% +$495K
FAST icon
20
Fastenal
FAST
$52B
$3.53M 1.8%
309,732
+29,696
+11% +$320K
LH icon
21
Labcorp
LH
$23.1B
$3.5M 1.79%
27,029
-29
-0.1% -$3.87K
UPS icon
22
United Parcel Service
UPS
$98.5B
$3.49M 1.78%
29,041
+375
+1% +$42.6K
CL icon
23
Colgate-Palmolive
CL
$73.3B
$3.47M 1.77%
47,628
+738
+2% +$53.2K
CHRW icon
24
C.H. Robinson
CHRW
$24.4B
$3.38M 1.73%
44,446
+2,110
+5% +$146K
CVS icon
25
CVS Health
CVS
$138B
$3.38M 1.73%
41,592
+6,405
+18% +$507K

Similar funds

Boston Research & Management's Q3 2017 Portfolio in Review

As of Q3 2017, Boston Research & Management held 98 positions worth $196M, up 5.9% from $185M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Boston Research & Management's Q3 2017 filing shows 3 new, 44 increased, 17 reduced and 2 closed positions. Its largest new stake was Tractor Supply: 220,950 shares worth $2.8M. The largest sale was Deere & Co, an estimated $3.43M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Boston Research & Management's largest Q3 2017 buy was Tractor Supply: 220,950 shares worth $2.8M.
  • Boston Research & Management added most to CVS Health in Q3 2017, an estimated $507K increase.
  • Boston Research & Management's biggest Q3 2017 reduction was Mastercard, cutting an estimated $172K.
  • Boston Research & Management fully exited Deere & Co in Q3 2017, selling an estimated $3.43M.
  • Boston Research & Management's ten largest holdings make up 23% of its $196M portfolio in Q3 2017.
  • Boston Research & Management opened 3 new positions and closed 2 in Q3 2017.
  • Boston Research & Management's portfolio value rose 5.9% quarter-over-quarter to $196M.

Based on Boston Research & Management's 13F filing for Q3 2017, filed 9 Nov 2017.